A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 1, 2011, Pages 19-23

  Hickerson, William L ^a   Nur, Israel ^b   Meidler, Roberto ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MRIX Biopharmaceuticals   (Israel)

Author keywords

EVICEL; factor XIII; fibrin clot; fibrin sealant; tensile strength; thromboelastography; TISSEEL; Young modulus

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRIN GLUE;

ARTICLE; BIOMECHANICS; BLOOD CLOTTING TIME; COMPARATIVE STUDY; ELASTICITY; FIBRIN CLOT; FORCE; PRIORITY JOURNAL; RIGIDITY; TENSILE STRENGTH; THROMBOELASTOGRAPHY; YOUNG MODULUS;

BLOOD COAGULATION; ELASTIC MODULUS; FACTOR XIII; FIBRIN TISSUE ADHESIVE; HEMOSTATICS; HUMANS; TENSILE STRENGTH; THROMBELASTOGRAPHY;

EID: 78650796250     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833fcbfb     Document Type: Article

References (18)

1. Albala DM, Lawson JH. Recent clinical and investigational applications of fibrin sealant in selected surgical specialties. J Am Coll Surg 2006; 202:685-697.
2. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004; 139:1148-1154.
3. Vaiman M, Sarfaty S, Shlamkovich N, Segal S, Eviatar E. Fibrin sealant: Alternative to nasal packing in endonasal operations. A prospective randomized study. Isr Med Assoc J 2005; 7:571-574.
4. Frilling A, Stavrou GA, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, et al. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: A randomised prospective trial. Langenbecks Arch Surg 2005; 390:114-120.
5. Schenk WG III, Burks SG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD. Fibrin sealant improves hemostasis in peripheral vascular surgery: A randomized prospective trial. Ann Surg 2003; 237:871-876.
6. Kassam A, Horowitz M, Carrau R, Snyderman C, Welch W, Hirsch B, et al. Use of Tisseel fibrin sealant in neurosurgical procedures: incidence of cerebrospinal fluid leaks and cost-benefit analysis in a retrospective study. Neurosurgery 2003; 52:1102-1105.
7. Foster JA, Holck DE, Perry JD, Wulc AE, Burns JA, Cahill KV, et al. Fibrin sealant for Müller muscle-conjunctiva resection ptosis repair. Ophthal Plast Reconstr Surg 2006; 22:184-187.
8. Shah HN, Hegde S, Shah JN, Mohile PD, Yuvaraja TB, Bansal MB. A prospective, randomized trial evaluating the safety and efficacy of fibrin sealant in tubeless percutaneous nephrolithotomy. J Urol 2006; 176:2488-2492.
9. Oliver DW, Hamilton SA, Figle AA, Wood SH, Lamberty BG. A prospective, randomized, double-blind trial of the use of fibrin sealant for face lifts. Plast Reconstr Surg 2001; 108:2101-2105; discussion.
10. EVICEL (Fibrin Sealant [Human]) [package insert]. Somerville, NJ: Johnson & Johnson Wound Management, a division of Ethicon, Inc.; 2008.
11. Longstaff C. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 1994; 5:537-542.
12. TISSEEL (Fibrin Sealant) [package insert]. Westlake Village, CA: Baxter Healthcare Corporation; 2007.
13. Isaacs JE, McDaniel CO, Owen JR, Wayne JS. Comparative analysis of biomechanical performance of available 'nerve glues'. J Hand Surg [Am] 2008; 33:893-899.
14. Velada JL, Hollingsbee DA, Menzies AR, Cornwell R, Dodd RA. Reproducibility of the mechanical properties of Vivostat system patient-derived fibrin sealant. Biomaterials 2002; 23:2249-2254.
15. Phillips M, Dickneite G, Metzner H. Fibrin sealants in supporting surgical techniques: Strength in factor XIII. Cardiovasc Surg 2003; 11 (Suppl 1): 13-16.
16. Mosesson MW. Fibrinogen and fibrin polymerization: Appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. Blood Coagul Fibrinolysis 1997; 8:257-267.
17. Dickneite G, Metzner H, Pfeifer T, Kroez M, Witzke G. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003; 112:73-82.
18. Kheirabadi BS,Pearson R, Tuthill D,Rudnicka K,Holcomb JB,Drohan W,et al. Comparative study of the hemostatic efficacy of a new humanfibrin sealant: is an antifibrinolytic agent necessary? J Trauma 2002; 52:1107-1115.